
Castle Biosciences, Inc.: A U.S. biotech firm offering diagnostic and prognostic cancer testing solutions.
Castle Biosciences, Inc. is a U.S.-based biotech company dedicated to providing diagnostic and prognostic testing solutions for cancer. The company's mission is to empower healthcare providers and patients by offering innovative tests that reveal a person's unique biology, thereby informing better disease management and treatment decisions. Castle Biosciences focuses on leveraging scientific rigor to improve patient outcomes through its comprehensive portfolio of diagnostic services.
Castle Biosciences has made significant strides in the biotech industry by developing advanced testing solutions that aid in the early detection and prognosis of various cancers. The company's impact is evident in its commitment to enhancing patient care and outcomes through personalized medicine. By focusing on the unique biological makeup of individuals, Castle Biosciences continues to play a crucial role in advancing cancer diagnostics and treatment strategies.

Predictive Biosciences

Biodesix
biodesix.com

Caris Life Sciences
carisls.com

Foundation Medicine

Guardant Health
guardanthealth.com

Oncocyte
oncocyte.com

Exact Sciences
exactsciences.com

GRAIL
grail.com

Biocept

Clovis Oncology

Epic Sciences
epicsciences.com

Accelerated Medical Diagnostics

Precipio
precipiodx.com

OncoHealth
oncohealthcorp.com

Myriad Genetics
myriad.com
Companies similar to Castle Biosciences include Predictive Biosciences, Biodesix, Caris Life Sciences and Foundation Medicine.
Castle Biosciences was founded in 2008.
Castle Biosciences' headquarters is located in Friendswood, TX, US.
Castle Biosciences' most recent funding round was for $266.8M (USD) in December 2020.
As of Dec 15, 2020, Castle Biosciences has raised a total of $354.3M (USD).
Castle Biosciences has 543 employees as of Feb 6, 2024.